Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

2,280 questions in 114 reviews · Cystic Fibrosis and Genetic Disorders

current versions
No studies 856 · 37.5%Ungraded 58 · 2.5%Very low 550 · 24.1%Low 502 · 22%Moderate 271 · 11.9%High 43 · 1.9%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Summary of findings: ECM vs ECT
CFA: change in FFE (g/day) · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted2 studies · 41 participantsLow
Summary of findings: ECM vs ECT
Adverse events · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECT
Pulmonary exacerbations · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Change in weight · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Change in height · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Change in BMI · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Frequency of bowel symptoms · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 54 participantsVery low
Summary of findings: ECM vs ECMM
CFA: change in FFE (g/day) · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 22 participantsVery low
Summary of findings: ECM vs NECT plus cimetidine
Change in height · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Adverse events · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs ECMM
Pulmonary exacerbations · children with cystic fibrosis and proven pancreatic insufficiency
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM (Creon®) vs a different ECM
Change in weight (kg) · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
MD 01 study · 83 participantsModerate
Summary of findings: ECM (Creon®) vs a different ECM
Change in height · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM (Creon®) vs a different ECM
Change in BMI · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM (Creon®) vs a different ECM
Frequency of bowel symptoms: proportion of days with abdominal pain · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
MD 01 study · 83 participantsLow
Summary of findings: ECM (Creon®) vs a different ECM
CFA: CFA (%) · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
MD 1.352 studies · 110 participantsModerate
Summary of findings: ECM (Creon®) vs a different ECM
Adverse events · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 83 participantsLow
Summary of findings: ECM (Creon®) vs a different ECM
Pulmonary exacerbations · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Change in weight (kg) · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 17 participantsVery low
Summary of findings: ECM vs NECT plus cimetidine
Change in BMI · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Change in height · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Change in BMI · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Frequency of bowel symptoms · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
CFA: change in FFE (g/day) · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 17 participantsVery low
Summary of findings: ECM vs TPE
Adverse events · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs TPE
Pulmonary exacerbations · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs other enteric‐coated preparations
Change in weight (kg) · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted2 studies · 56 participantsVery low
Summary of findings: ECM vs other enteric‐coated preparations
Change in height · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 45 participantsVery low
Summary of findings: ECM vs other enteric‐coated preparations
Change in BMI · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs other enteric‐coated preparations
Frequency of bowel symptoms: stool frequency · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted2 studies · 56 participantsVery low
Summary of findings: ECM vs NECT plus cimetidine
Frequency in bowel symptoms: abdominal pain (% of days affected) · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 12 participantsVery low
Summary of findings: ECM vs other enteric‐coated preparations
CFA: fat absorption · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted2 studies · 56 participantsVery low
Summary of findings: ECM vs other enteric‐coated preparations
Adverse events · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs other enteric‐coated preparations
Pulmonary exacerbations · children with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: low‐dose vs high‐dose PERT
Change in weight (kg) · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 17 participantsVery low
Summary of findings: low‐dose vs high‐dose PERT
Change in height · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: low‐dose vs high‐dose PERT
Change in BMI · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: low‐dose vs high‐dose PERT
Frequency of bowel symptoms: stool frequency · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 17 participantsVery low
Summary of findings: low‐dose vs high‐dose PERT
CFA: FFE (g/day) · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 17 participantsVery low
Summary of findings: low‐dose vs high‐dose PERT
Adverse events · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted2 studies · 146 participantsVery low
Summary of findings: low‐dose vs high‐dose PERT
Pulmonary exacerbations · children and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: ECM vs NECT plus cimetidine
CFA: change in FFE (g/day) · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 12 participantsLow
Summary of findings: liprotamase vs porcine PERT
Change in weight (kg) · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 128 participantsLow
Summary of findings: liprotamase vs porcine PERT
Change in height · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: liprotamase vs porcine PERT
Change in BMI · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies
Summary of findings: liprotamase vs porcine PERT
Frequency of bowel symptoms: abdominal pain · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 128 participantsLow
Summary of findings: liprotamase vs porcine PERT
CFA: change from baseline (%) · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 128 participantsLow
Summary of findings: liprotamase vs porcine PERT
Adverse events · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extracted1 study · 128 participantsLow
Summary of findings: liprotamase vs porcine PERT
Pulmonary exacerbations: number of exacerbations · children aged 7 years or over and adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
OR 0.56 [0.13, 2.45]1 study · 128 participantsLow
Summary of findings: ECM vs NECT plus cimetidine
Adverse events · adults with cystic fibrosis
Pancreatic enzyme replacement therapy for people with cystic fibrosis (2020) · Cochrane
no estimate extractedNRNo studies